The Thailand Center of Excellence for Life Sciences is planning to encourage local researchers to develop a generic human papillomavirus vaccine, the Bangkok Post reports. The Center's president, Pornchai Matangkasombut, speaking at the BioAsia 2008 Thailand conference, called on the Thai Red Cross and the Government Pharmaceutical Organization, along with other non-governmental organizations to participate in the effort. Dr Pornchai made the announcement after a meeting with 2008 Nobel Prize in Medicine winner Harald zur Hausen, the German scientist who pioneered the genetic research that made an HPV vaccine possible.
Cervical cancer claims the life of one woman every four hours in Thailand, according to the TCELS, with rates of the disease considerably higher in a tropical climate than in temperate zones. Dr zur Hausen warned that developing a local vaccine would not be straighforward. He said: "it's not easy to make the vaccine. India and China have been working on it for at least two years and have made a lot of progress."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze